NO994049D0 - Metode for å fremstille farmasöytiske forbindelser - Google Patents
Metode for å fremstille farmasöytiske forbindelserInfo
- Publication number
- NO994049D0 NO994049D0 NO994049A NO994049A NO994049D0 NO 994049 D0 NO994049 D0 NO 994049D0 NO 994049 A NO994049 A NO 994049A NO 994049 A NO994049 A NO 994049A NO 994049 D0 NO994049 D0 NO 994049D0
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical compounds
- preparing pharmaceutical
- preparing
- compounds
- pharmaceutical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/40—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by ester radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3911497P | 1997-02-26 | 1997-02-26 | |
US3911697P | 1997-02-26 | 1997-02-26 | |
PCT/US1998/003655 WO1998038158A1 (en) | 1997-02-26 | 1998-02-25 | Process for preparing pharmaceutical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
NO994049L NO994049L (no) | 1999-08-23 |
NO994049D0 true NO994049D0 (no) | 1999-08-23 |
Family
ID=26715826
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994049A NO994049D0 (no) | 1997-02-26 | 1999-08-23 | Metode for å fremstille farmasöytiske forbindelser |
NO994083A NO994083L (no) | 1997-02-26 | 1999-08-24 | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO994083A NO994083L (no) | 1997-02-26 | 1999-08-24 | Selektiv epoksideringsmetode for fremstilling av farmasöytiske forbindelser |
Country Status (17)
Country | Link |
---|---|
US (1) | US6143909A (cs) |
EP (2) | EP0861838A3 (cs) |
JP (2) | JP2002513403A (cs) |
KR (2) | KR20000075671A (cs) |
CN (2) | CN1252788A (cs) |
AU (2) | AU6667198A (cs) |
BR (2) | BR9807265A (cs) |
CA (2) | CA2281104A1 (cs) |
CZ (1) | CZ9902998A3 (cs) |
EA (2) | EA199900770A1 (cs) |
ID (2) | ID24527A (cs) |
IL (2) | IL131162A0 (cs) |
NO (2) | NO994049D0 (cs) |
NZ (1) | NZ336918A (cs) |
PL (2) | PL335347A1 (cs) |
TR (2) | TR199902064T2 (cs) |
WO (2) | WO1998038158A1 (cs) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001500484A (ja) * | 1996-08-30 | 2001-01-16 | イーライ・リリー・アンド・カンパニー | 医薬化合物の製造法 |
JP2001506970A (ja) * | 1996-09-06 | 2001-05-29 | イーライ・リリー・アンド・カンパニー | 方法及び新規な中間体 |
AU1123200A (en) * | 1998-10-16 | 2000-05-08 | Eli Lilly And Company | Stereoselective process for producing antineoplastic agents |
WO2000034253A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Intermediates and reaction sequence to produce said intermediates useful for the preparation of antineoplastic and antifungal cryptophycin derivatives |
WO2000034252A2 (en) * | 1998-12-07 | 2000-06-15 | Eli Lilly And Company | Process for the preparation of cryptophycin derivatives |
AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
EP1751279A4 (en) * | 2004-05-05 | 2008-03-19 | Univ Minnesota | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PREPARATION OF CRYPTOPHYCIN |
CN101962323B (zh) * | 2010-07-16 | 2013-06-05 | 中国人民解放军第二军医大学 | 2-丙烯酰x基-3-取代苯基丙酸类化合物及其用途 |
CN111333560B (zh) * | 2020-04-13 | 2024-01-23 | 合肥工业大学 | 一种制备螺环β-内酰胺的方法 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4946835A (en) * | 1988-07-15 | 1990-08-07 | Merck & Co., Inc. | Antifungal fermentation product and method |
US4868208A (en) * | 1988-07-15 | 1989-09-19 | Merck & Co., Inc. | Antifungal agent and method |
US4845085A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
US4845086A (en) * | 1988-08-09 | 1989-07-04 | Merck & Co., Inc. | Antifungal agent |
CA2047191A1 (en) * | 1989-02-17 | 1990-08-18 | Hendrik M. Geysen | Method for the use and synthesis of peptides |
US5256802A (en) * | 1990-04-03 | 1993-10-26 | Miles Inc. | Process for the production of oxiranes |
HUT73150A (en) * | 1992-11-06 | 1996-06-28 | Chiron Mimotopes Pty Ltd | Modular polymer and support for the synthesis thereof |
GB2282384B8 (en) * | 1993-08-18 | 1997-09-04 | Europ Economic Community | Drug delivery agents incorporating mitomycin |
WO1995017093A1 (en) * | 1993-12-21 | 1995-06-29 | University Of Hawaii | New cryptophycins |
US5952298A (en) * | 1993-12-21 | 1999-09-14 | The University Of Hawaii | Cryptophycins |
ATE191917T1 (de) * | 1994-10-14 | 2000-05-15 | Stratagene Inc | Porphyrin-markierung von polynukleotiden |
MD2196B2 (ro) * | 1995-03-07 | 2003-06-30 | Юнивэсити Эв Хауайи | Criptoficine, procedeu de obţinere, compoziţii farmaceutice pe baza acestora, metodă de inhibare a proliferării celulelor mamiferelor şi metodă de atenuare a stării patologice cauzate de hiperproliferarea celulelor mamiferelor |
CA2217051C (en) * | 1995-03-31 | 2006-05-30 | Nippon Chemiphar Co., Ltd. | Epoxysuccinic acid derivatives |
US5700826A (en) * | 1995-06-07 | 1997-12-23 | Ontogen Corporation | 1,2,4,5-tetra substituted imidazoles as modulators of multi-drug resistance |
JP2000501067A (ja) * | 1995-08-30 | 2000-02-02 | イーライ・リリー・アンド・カンパニー | 医薬化合物 |
CA2241086A1 (en) * | 1995-12-22 | 1997-07-03 | University Of Hawai'i | Pharmaceutical compounds |
US5843865A (en) * | 1996-02-07 | 1998-12-01 | Buckman Laboratories International, Inc. | Synergistic antimicrobial compositions containing an ionene polymer and a salt of dodecylamine and methods of using the same |
DE69704731D1 (de) * | 1996-02-27 | 2001-06-13 | Lilly Co Eli | Cryptophycinderivate und ihre Verwendung als antimikrotubuli Mittel |
JP2001502297A (ja) * | 1996-08-30 | 2001-02-20 | イーライ・リリー・アンド・カンパニー | 医薬用化合物 |
IL128610A (en) * | 1996-08-30 | 2004-07-25 | Lilly Co Eli | Cryptophycin compound and its use as a medicament for treating neoplasm |
JP2001500853A (ja) * | 1996-08-30 | 2001-01-23 | イーライ・リリー・アンド・カンパニー | 医薬化合物 |
US6025506A (en) * | 1997-02-21 | 2000-02-15 | Dsm N.V. | Process for preparing an optically active phenylglycidyl acid derivative |
IL123352A0 (en) * | 1997-02-27 | 1998-09-24 | Tanabe Seiyaku Co | Process for preparing an optically active trans-3-substituted glycidic acid ester |
-
1998
- 1998-02-25 NZ NZ336918A patent/NZ336918A/en unknown
- 1998-02-25 WO PCT/US1998/003655 patent/WO1998038158A1/en active Search and Examination
- 1998-02-25 KR KR1019997007737A patent/KR20000075671A/ko not_active Application Discontinuation
- 1998-02-25 CA CA002281104A patent/CA2281104A1/en not_active Abandoned
- 1998-02-25 BR BR9807265-0A patent/BR9807265A/pt unknown
- 1998-02-25 JP JP53780398A patent/JP2002513403A/ja active Pending
- 1998-02-25 AU AU66671/98A patent/AU6667198A/en not_active Abandoned
- 1998-02-25 US US09/380,005 patent/US6143909A/en not_active Expired - Fee Related
- 1998-02-25 KR KR1019997007686A patent/KR20000075623A/ko not_active Application Discontinuation
- 1998-02-25 TR TR1999/02064T patent/TR199902064T2/xx unknown
- 1998-02-25 JP JP53779998A patent/JP2002512603A/ja active Pending
- 1998-02-25 ID IDW990900D patent/ID24527A/id unknown
- 1998-02-25 CZ CZ19992998A patent/CZ9902998A3/cs unknown
- 1998-02-25 AU AU66672/98A patent/AU738999B2/en not_active Ceased
- 1998-02-25 TR TR1999/02065T patent/TR199902065T2/xx unknown
- 1998-02-25 IL IL13116298A patent/IL131162A0/xx unknown
- 1998-02-25 EP EP98301367A patent/EP0861838A3/en not_active Withdrawn
- 1998-02-25 ID IDW990901A patent/ID22984A/id unknown
- 1998-02-25 EP EP98301368A patent/EP0861839A1/en not_active Ceased
- 1998-02-25 CN CN98804250A patent/CN1252788A/zh active Pending
- 1998-02-25 EA EA199900770A patent/EA199900770A1/ru unknown
- 1998-02-25 PL PL98335347A patent/PL335347A1/xx unknown
- 1998-02-25 BR BR9811252-0A patent/BR9811252A/pt not_active IP Right Cessation
- 1998-02-25 WO PCT/US1998/003667 patent/WO1998038164A1/en not_active Application Discontinuation
- 1998-02-25 EA EA199900772A patent/EA002547B1/ru not_active IP Right Cessation
- 1998-02-25 PL PL98335478A patent/PL335478A1/xx unknown
- 1998-02-25 CN CN98804251A patent/CN1255121A/zh active Pending
- 1998-02-25 CA CA002281108A patent/CA2281108A1/en not_active Abandoned
- 1998-02-25 IL IL13120598A patent/IL131205A0/xx unknown
-
1999
- 1999-08-23 NO NO994049A patent/NO994049D0/no not_active Application Discontinuation
- 1999-08-24 NO NO994083A patent/NO994083L/no not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI973518A (fi) | Farmaseuttinen koostumus piperidinoalkanoliyhdisteille | |
PT892640E (pt) | Composicoes farmaceuticas de micofenolato entericamente revestidas | |
NO994757L (no) | Fremgangsmåte for oral administrasjon av proteiner | |
NO995681D0 (no) | Fremgangsmåte for å fremstille fluorbiprofen-tabletter | |
AR017655A1 (es) | Metodo para preparar eteres de monofluormetilo | |
NO995251D0 (no) | FremgangsmÕte for administrering av haloterapi | |
BR9610214A (pt) | Compostos farmacéuticos | |
NO974169D0 (no) | Fremgangsmåte for tetra-azacykloalkan-fremstilling | |
NO20001728D0 (no) | Fremgangsmåte for fremstilling av chirale forbindelser | |
ID28601A (id) | Proses penyiapan senyawa-senyawa 1,4-dihidropiridin | |
IT1272922B (it) | Procedimento per la preparazione di composti metallocenici | |
NO994049D0 (no) | Metode for å fremstille farmasöytiske forbindelser | |
ID22840A (id) | Proses untuk penyiapan komposisi aspal | |
NO995851D0 (no) | Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse | |
TR199800403A3 (tr) | a-Bromo-laktam türevlerinin hazirlanmasi için yöntem. | |
EE9800195A (et) | Uudsed analgeetilise toimega ühendid | |
NO20001777D0 (no) | Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer | |
NO996432D0 (no) | Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider | |
ID22430A (id) | Proses pembuatan senyawa-senyawa benzotiazolona | |
NO993863D0 (no) | Forbindelser og fremgangsmåte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer | |
EE200000401A (et) | Farmatseutilise preparaadi valmistamismeetod | |
NO965448L (no) | Farmasöytiske forbindelser | |
NO20003145D0 (no) | FremgangsmÕte for fremstilling av paroxetine-hydroklorid | |
NO980316D0 (no) | Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam | |
EG21226A (en) | Process for preparing of new pharmaceutical compound |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |